Map pointer

3855 SW 153rd Drive, Beaverton, Oregon 97003

Email icon

News

‘SC Administration and Immunogenicity Risk; Current Understanding and Future Considerations for Novel Modalities’

In order to focus on the most important considerations for SC product development, developers must have a data-driven understanding of......
Read More

Notification of Virtual Workshop ‘Roadmapping the Clinical and Regulatory Paths of SC Products and Technologies’

The Clinical Development & Regulatory Strategy (CDRS) sub-team of the Subcutaneous (SC) Drug Development and…...
Read More
en_USEnglish